Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: Behavioral and in vivo microdialysis studies

Behavioural Brain Research

Volumn 78, Issue 2, 1996, Pages 211-223

  Rui Qian, Wan ^a,b   Giovanni, Andrew ^a   Kafka, Sharon H ^a   Corbett, Roy ^a  

^a SANOFI   (France)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amphetamine; Dopamine; Hippocampus; Locomotion; Microdialysis; Neonatal lesions; Nucleus accumbens

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; AMPHETAMINE; DOPAMINE; HOMOVANILLIC ACID; IBOTENIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; LOCOMOTION; MALE; MICRODIALYSIS; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT;

EID: 0030221656     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(95)00251-0     Document Type: Article

References (51)

1. [1] Beckmann, H., Gattaz, W.F. and Jakob, H., Biochemical and neuropathological indices for the aetiology of schizophrenia. In H. Haffiner, W.F. Gattaz and W. Janzarik (Eds.), Search for the Causes of Schizophrenia, Springer-Verlag, New York, 1987.
2. [2] Bell, D.S., Comparison of amphetamine psychosis and schizophrenia, Br. J. Psychiatry, 3 (1965) 701-707.
3. [3] Bloom, F.E., Advancing a neurodevelopmental origin for schizophrenia, Arch. Gen. Psychiatry, 50 (1993) 224-227.
4. [4] Bogerts, B., Recent advances in the neuropathology of schizophrenia, Schizophr. Bull., 19 (1993) 431-445.
5. [5] Breese, G.R., Napier, T.C. and Mueller, R.A., Dopamine agonist-induced locomotor activity in rats with 6-hydroxydopamine at differing ages: functional supersensitivity of D1 receptors in neonatally lesioned rats, J. Pharmacol. Exp. Ther., 234 (1985) 447-455.
6. [6] Brown, R., Colter, N., Corsellis, J.A.N., Crow, T.J., Frith, C.D., Jagoe, R., Johnstone, E.C. and Marsh, L., Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder, Arch. Gen. Psychiatry, 43 (1986) 36-42.
7. [7] Cooper, J.R., Bloom, F.E. and Roth, R.H., The Biochemical Basis of Neuropharmacology, 6th ed., Oxford University Press, New York, 1991.
8. [8] Crow, T.J., Positive and negative schizophrenic symptoms and role of dopamine, Br. J. Psychiatry, 137 (1980) 383-386.
9. [9] Crow, T.J. and Johnston, E.C., Schizophrenia: nature of the disease process and its biological correlates. In V.B. Mountcastle and F. Plum (Eds.), Handbook of Physiology: The Nervous System, Vol. 5, American Physiological Society, Baltimore, MD, 1986, pp. 834-869.
10. [10] Douglas, R.J. and Isaacson, R.L., Hippocampal lesions and activity, Psychon. Sci., 1 (1964) 187-188.
11. [11] Erinoff, L. and Snodgrass, S.R., Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels and response to caffeine, Pharmacol. Biochem. Behav., 24 (1986) 1039-1045.
12. [12] Falkai, P. and Bogerts, B., Cell loss in the hippocampus of schizophrenics, Eur. Arch. Psychiatry Neurol. Sci., 236 (1986) 154-161.
13. [13] Fibiger, H.C., The dopamine hypotheses of schizophrenia and mood disorders: contradictions and speculations. In P. Willner and J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From Motivation to Action, John Wiley and Sons, Chichester, 1991, pp. 615-637.
14. [14] Gong, L., Kostrzewa, R.M., Brus, R., Fuller, R.W. and Perry, K.W., Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats, Dev. Brain Res., 76 (1993) 59-65.
15. [15] Gray, J.A., Feldon, J., Rawlins, J.N.P, Hemsley, D.R. and Smith, A.D., The neuropsychology of schizophrenia, Behav. Brain Sci., 14 (1991) 1-84.
16. [16] Groenewegen, H.J., Berebdse, H.W., Meredith, G.E., Haber, S.N., Voorn, P., Wolters, J.G. and Lohman, A.H.M., Functional Anatomy of the ventral, limbic system-innervated striatum. In P. Willner and J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From Motivation to Action, John Wiley and Sons, Chichster, 1991, pp. 19-59.
17. [17] Hall, L.D., Herrod, J.J., Carpenter, T.A. and McKenna, P.J., Magnetic resonance imagine in schizophrenia: A review of clinical and methodological issues. In R.J. Ancill, S. Holliday and J. Hihenbottam (Eds.), Schizophrenia: Exploring the Spectrum of Psychosis, John Wiley and Sons, Chichester, 1994, pp. 115-135.
18. [18] Jarrard, L.E., On the role of the hippocampus in learning and memory, Behav. Neural Biol., 60 (1993) 9-26.
19. [19] Jarrad, L.E., Behavior of hippocampal lesioned rats in home cage and novel situations, Physiol. Behav., 3 (1968) 65-70.
20. [20] Jaskiw, G.E. and Weinberger, D.R., Dopamine and schizophrenia - a cortically correct perspective, Sem. Neurosci., 4 (1992) 179-189.
21. [21] Javitt, D.C. and Zukin, S.R., Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry, 148 (1991) 1301-1308.
22. [22] Kerwin, R.W. and Murray, R.M., A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia, Schizo. Res., 7 (1992) 1-12.
23. [23] Kelly, P.H. and Roberts, D.S.C., Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi, Pharmacol. Biochem. Behav., 19 (1983) 137-143.
24. [24] Kelly, P.H., Seviour, P.W. and Iversen, S.D., Amphetamine and apomorphine responses following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum, Brain Res., 94 (1975) 507-522.
25. [25] Kimble, D.P., The effects of bilateral hippocampal lesions in rats, J. Comp. Physiol. Psychol., 2 (1963) 273-283.
26. [26] Knable, M.B., Murray, A.M., Lipska, B.K., Karoum, F. and Weinberger, D.R., D2/D3 and D4 receptor densities are not altered in rats with neonatal hippocampal damage, Soc. Neurosci. Abstr., (1994) 513.3.
27. [27] Kotrla, K.J. and Weinberger, D.R., A neurodevelopmental perspective on normal brain functioning, plasticity and schizophrenia. In R.J. Ancill, S. Holliday and J. Hihenbottam (Eds.), Schizophrenia: Exploring the Spectrum of Psychosis, John Willey and Sons, Chichester, 1994, pp. 67-93.
28. [28] Laplane, D., Levasseur, M., Pillon, B., Dubois, B., Baulac, M., Mazoyer, B., Tran Dinh, S., Sette, G., Danze, F. and Baron, J.C., Obsessive-compulsive and other behavioral changes with bilateral basal ganglia lesions, Brain, 32 (1989) 699-725.
29. [29] Lipska, B.K. and Weinberger, D.R., Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphin-induced Stereotypic behaviors in the rat, Dev. Brain Res., 75 (1993) 213-222.
30. [30] Lipska, B.K., Jaskiw, G.E. and Weinberger, D.R., Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia, Neuropsychopharmacology, 9 (1993) 67-75.
31. [31] Lipska, B.K., Jaskiw, G.E., Chrapusta, S., Karoum, F. and Weinberger, D.R., Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat, Brain Res., 585 (1992) 1-6.
32. [32] Lopes da Silva, F.H., Arnolds, D.E.A. and Neijt, H.C., A functional link between the limbic cortex and ventral striatum: physiology of subiculum accumbens pathway, Exp. Brain Res., 55 (1984) 205-14.
33. [33] Lyon, M. and Robbins, T.W., The action of central nervous system drugs: a general theory concerning amphetamine effects. In W. Essman and L. Valzelli, (Eds.), Current Developments in Psychopharmacology, Vol. 2, Spectrum, New York, 1975, pp. 79-163.
34. [34] Mednick, S.A., Cannon, T.D., Barr, C.E. and Lyon, M., Fetal Neural Development and Adult Schizophrenia, Cambridge University Press, Cambridge, 1991.
35. [35] Mittleman, G., LeDuc, P.A. and Whishaw, I.Q., The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia, Behav. Brain Res., 55 (1993) 253-267.
36. [36] Moody, C.A. and Spear, L.P., Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weaning age period, Psychopharmacology, 106 (1992) 161-168.
37. [37] Paxinos, G. and Watson, C., The rat brain in stereotaxic coordinates (2nd ed.), Academic Press, San Diego, CA, 1986.
38. [38] Phillips, I., Lipska, B.K., Bigelow, L.B. and Weinberger, D.R., Strain differences in behavioral abnormalities associated with neonatal excitotoxic hippocampal damage in the rat, Soc. Neurosci. Abstr., 20 (1994) 513.6.
39. [39] Pijnenburg, A.J.J. and Van Rossum, J.M., Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens, J. Pharm. Pharmacol., 25 (1973) 1003-1005.
40. [40] Pijnenburg, A.J.J., Honing, W.M.M, Van Der Heyden, J.A..M. and Van Rossum, J.M., Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity, Eur. J. Pharmacol., 35 (1976) 45-48.
41. [41] Randolph, C., Goldberg, T.E. and Weinberger, D.R., The neuropsychology of schizophrenia. In K.M. Heilman and E. Valenstein (Eds.), Clinical Neuropsychology, 3rd ed., Oxford, New York, 1993, pp. 499-522.
42. [42] Snyder, S.H., Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines, Am. J. Psychiatry, 130 (1973) 61-67.
43. [43] Squire, L.R., Memory and the hippocampus: A synthesis from finding with rats, monkeys, and humans, Psychol. Rev., 99 (1992) 195-231.
44. [44] Suess, W. M. and Berlyne, P.E., Exploratory behavior as a function of hippocampal damage, stimulus complexity, and stimulus mostly in the hooded rat, Behav. Biol., 23 (1978) 487-499.
45. [45] Swerdlow, N.R. and Koob, G.F., Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of corticostriato-pallidothalamic function, Behav. Brain Sci., 10 (1987) 197-245.
46. [46] Totterdell, S. and Smith, A.D., Convergence of hippocampal and dopaminergic input onto identified neurons of the nucleus accumbens of the rat, J. Chem. Neuroanat., 2 (1989) 285-298.
47. [47] Ungerstedt, U., Measurement of neurotransmitter release by intracranial dialysis. In C.A. Marsden (Ed.), Measurement of neurotransmitter release in vivo, Wiley, Chichester, 1984.
48. [48] Weinberger, D.R., Implication of normal brain development for the pathogenesis of schizophrenia, Arch. Gen. Psychiatry, 44 (1987) 660-669.
49. [49] Wilkinson, L.S., Mittleman, G., Torres, E., Humby, T., Hall, F.S. and Robbins, T.W., Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus, Behav. Brain Res., 55 (1993) 143-150.
50. [50] Whishaw, I.Q. and Mittleman, G., Hippocampal modulation of nucleus accumbens: Behavioral evidence from amphetamine-induced activity profiles, Behav. Neural Biol., 55 (1991) 289-306.
51. [51] Zetterstrom, T., Marsden, C.A. and Ungerstedt, U., In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine, J. Neurochem., 41 (1983) 1769-1773.